Activation of δ-globin gene expression by erythroid Krupple-like factor: A potential approach for gene therapy of sickle cell disease

Blood

Volumn 88, Issue 10, 1996, Pages 4051-4057

  Donze, David ^a   Jeancake, Paxson H ^a   Townes, Tim M ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLOBIN; DELTA GLOBIN; HEMOGLOBIN A2; MESSENGER RNA; TRANSCRIPTION FACTOR; ZINC FINGER PROTEIN;

ANIMAL CELL; ARTICLE; BINDING SITE; CELL TRANSFORMATION; CONTROLLED STUDY; ERYTHROLEUKEMIA CELL; GENE EXPRESSION; GENE INSERTION; GENE THERAPY; MOUSE; NONHUMAN; PLASMID; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; REPORTER GENE; SICKLE CELL ANEMIA;

EID: 0029850721     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.10.4051.bloodjournal88104051     Document Type: Article

References (37)

1. McCune SL, Reilly MP, Chomo MJ, Asakura T, Townes TM: Recombinant human hemoglobins designed for gene therapy of sickle cell disease. Proc Natl Acad Sci USA 91:9852, 1994
2. Miller JL, Donahue RE, Sellers SE, Samulski RJ, Young NS, Nienhuis AW: Recombinant adeno-associated virus (rAAV)-mediated expression of a human gamma-globin gene in human progenitor-derived erythroid cells. Proc Natl Acad Sci USA 91:10183, 1994
3. Einerhand MP, Antoniou M, Zolotukhin S, Muzyczka N, Berns KI, Grosveld F, Valerio D: Regulated high-level human beta-globin gene expression in erythroid cells following recombinant adeno-associated virus-mediated gene transfer. Gene Ther 2:336, 1995
4. Takekoshi KJ, Oh YH, Westerman KW, London IM, Leboulch P: Retroviral transfer of a human beta-globin/delta-globin hybrid gene linked to beta locus control region hypersensitive site 2 aimed at the gene therapy of sickle cell disease. Proc Natl Acad Sci USA 92:3014, 1995
5. Palmer TD, Rosman GJ, Osborne WRA, Miller D: Genetically modified skin fibroblasts persist long after transplantation but gradually inactivate introduced genes. Cell 88:1330, 1991
6. Weatherall DJ: Gene therapy in perspective. Nature 349:275, 1991
7. McCune SL, Townes TM: Retroviral vector sequences inhibit human beta-globin gene expression in transgenic mice. Nucleic Acids Res 22:4477, 1994
8. 2 on the polymerization of hemoglobin S. Proc Natl Acad Sci USA 76:670, 1979
9. 2: Origin, evolution, and aftermath. Blood 78:2165, 1991
10. Dierks PA, van Ooyen A, Cochran MD, Dobkin C, Reiser J, Weissman C: Three regions upstream from the cap site are required for efficient and accurate transcription of the rabbit β-globin gene in mouse 3T3 cells. Cell 32:695, 1983
11. Myers RM, Tilly K, Maniatis T: Fine structure genetic analysis of a β-globin promoter. Science 232:613, 1986
12. Cowie A, Myers R: DNA sequences involved in transcriptional regulation of the mouse β-globin promoter in murine erythroleukemia cells. Mol Cell Biol 8:3122, 1988
13. Miller IJ, Bieker JJ: A novel, erythroid cell-specific murine transcription factor that binds to the CACCC element and is related to the Kruppel family of nuclear proteins. Mol Cell Biol 13:2776, 1993
14. Donze D, Townes TM, Bieker JJ: Role of the erythroid Kruppel-like factor in human γ to β-globin gene switching. J Biol Chem 270:1955, 1995
15. Nuez B, Michalovich D, Bygrave A, Ploemacher R, Grosveld F: Defective haemotopoiesis in fetal liver resulting from inactivation of the EKLF gene. Nature 375:316, 1995
16. Perkins AC, Sharpe AH, Orkin SH: Lethal β-thalassaemia in mice lacking the erythroid CACCC-transcription factor EKLF. Nature 375:318, 1995
17. Caterina JJ, Donze D, Sun C-W, Ciavatta DJ, Townes TM: Cloning and functional characterization of LCR-F1: A novel transcription factor that activates erythroid-specific, human globin gene expression. Nucleic Acids Res 22:2383, 1994
18. Sarkar G, Sommer SS: The "megaprimer" method of site-directed mutagenesis. Biotechniques 8:404, 1990
19. Barik S, Galinski M: "Megaprimer" method of PCR: Increased template concentration improves yield. Biotechniques 10:489, 1991
20. Aiyar A, Leis J: Modification of the megaprimer method of PCR mutagenesis: Improved amplification of the final product. Biotechniques 14:366, 1993
21. Giniger E, Varnum S, Ptashne M: Specific DNA binding of GAL4, a positive regulatory protein of yeast. Cell 40:767, 1985
22. Caterina JJ, Ciavatta DJ, Donze D, Behringer RR, Townes TM: Multiple elements in human β-globin locus control region 5′ HS 2 are involved in enhancer activity and position-independent, transgene expression. Nucleic Acids Res 22:1006, 1994
23. Collis P, Antoniou M, Grosveld F: Definition of the minimal requirements within the human β-globin gene and the dominant control region for high level expression. EMBO J 9:233, 1990
24. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156, 1987
25. Szabo PE, Mann JR: Biallelic expression of imprinted genes in the mouse germline: Implications for erasure, establishment, and mechanisms of genomic imprinting. Genes Dev 9:1857, 1995
26. Rahuel C, Vinit MA, Lemarchandel V, Cartron JP, Romeo PH: Erythroid-specific activity of the glycophorin B promoter requires GATA-1 mediated displacement of a repressor. EMBO J 11:4095, 1992
27. Genetta T, Ruezinsky D, Kadesch T: Displacement of an E-box-binding repressor by basic helix-loop-helix proteins: Implications for B-cell specificity of the immunoglobulin heavy-chain enhancer. Mol Cell Biol 14:6153, 1994
28. Kosche KA, Dobkin C, Bank A: DNA sequences regulating human β-globin gene expression. Nucleic Acids Res 13:7781, 1985
29. Behringer RR, Hammer RE, Brinster RL, Palmiter RD, Townes TM: Two 3′ sequences direct adult erythroid-specific expression of human β-globin genes in transgenic mice. Proc Natl Acad Sci USA 84:7056, 1987
30. Ross J, Pizarro A: Human β- and δ-globin messenger RNAs turn over at different rates. J Mol Biol 167:607, 1983
31. Platt LS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, Klug PP: Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med 330:1639, 1994
32. Smith G: Filamentous fusion phage: Novel expression vectors that display cloned antigens on the virion surface. Science 228:1315, 1985
33. Choo Y, Klug A: Toward a code for the interactions of zinc fingers with DNA: Selection of randomized fingers displayed on phage. Proc Natl Acad Sci USA 91:11163, 1994
34. Jamieson AC, Kim S-H, Wells JA: In vitro selection of zinc fingers with altered DNA binding specificity. Biochemistry 33:5689, 1994
35. Rebar EJ, Pabo CO: Zinc finger phage: Affinity selection of fingers with new DNA binding specificities. Science 263:671, 1994
36. Wu H, Yang W-P, Barbas CF: Building zinc fingers by selection: Toward a therapeutic application. Proc Natl Acad Sci USA 92:344, 1995
37. Choo Y, Sanchez-Garcia I, Klug A: In vivo repression by a site-specific DNA-binding protein designed against an oncogenic sequence. Nature 372:642, 1994